Bio-Leo Analytical Labs India Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 21-12-2024
- Paid Up Capital ₹ 2.80 M
as on 21-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.50 M
as on 21-12-2024
- Revenue -2.83%
(FY 2021)
- Profit 220.06%
(FY 2021)
- Ebitda 66.11%
(FY 2021)
- Net Worth 86.71%
(FY 2021)
- Total Assets 1.87%
(FY 2021)
About Bio-Leo Analytical Labs India
The Corporate was formerly known as Vls Analytical Labs Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 2.80 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hema Puthineedi and Mohana Rajkumar serve as directors at the Company.
- CIN/LLPIN
U24232AP2010PTC071965
- Company No.
071965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bio-Leo Analytical Labs India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hema Puthineedi  | Director | 27-Feb-2016 | Current |
| Mohana Rajkumar | Director | 09-May-2016 | Current |
Financial Performance of Bio-Leo Analytical Labs India.
Bio-Leo Analytical Labs India Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.83% decrease. The company also saw a substantial improvement in profitability, with a 220.06% increase in profit. The company's net worth Soared by an impressive increase of 86.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Leo Analytical Labs India?
In 2021, Bio-Leo Analytical Labs India had a promoter holding of 93.00% and a public holding of 7.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 06 Feb 2012 | ₹1.50 M | Satisfied |
Andhra Pradesh State Finance Corporation Creation Date: 18 Apr 2011 | ₹6.00 M | Satisfied |
How Many Employees Work at Bio-Leo Analytical Labs India?
Unlock and access historical data on people associated with Bio-Leo Analytical Labs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Leo Analytical Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Leo Analytical Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
